青少年特发性关节炎中的生物制剂
Biologicals in Juvenile Idiopathic Arthritis.
作者信息
Saini Isha, Dawman Lesa, Gupta Neerja, Kabra S K
机构信息
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
出版信息
Indian Pediatr. 2016 Mar;53(3):260-1.
PMID:27029697
Abstract
We share our experience with biological agents in children with juvenile idiopathic arthritis with an aim to highlight the adverse events and response to treatment. Out of a total of 10 children treated with biological agents, one patient had serious infection, all showed good response and none had tuberculosis. High cost was limiting factor for their use.
摘要
我们分享了在幼年特发性关节炎患儿中使用生物制剂的经验，旨在突出不良事件及治疗反应。在总共10名接受生物制剂治疗的儿童中，1例患者发生严重感染，所有患者均显示出良好反应，且无1例发生结核病。高成本是限制其使用的因素。
Zotero 插件